134 related articles for article (PubMed ID: 32029900)
1. ERBB3-induced furin promotes the progression and metastasis of ovarian cancer via the IGF1R/STAT3 signaling axis.
Chen C; Gupta P; Parashar D; Nair GG; George J; Geethadevi A; Wang W; Tsaih SW; Bradley W; Ramchandran R; Rader JS; Chaluvally-Raghavan P; Pradeep S
Oncogene; 2020 Apr; 39(14):2921-2933. PubMed ID: 32029900
[TBL] [Abstract][Full Text] [Related]
2. AKT2 contributes to increase ovarian cancer cell migration and invasion through the AKT2-PKM2-STAT3/NF-κB axis.
Zheng B; Geng L; Zeng L; Liu F; Huang Q
Cell Signal; 2018 May; 45():122-131. PubMed ID: 29374601
[TBL] [Abstract][Full Text] [Related]
3. Elevated STAT3 expression in ovarian cancer ascites promotes invasion and metastasis: a potential therapeutic target.
Saini U; Naidu S; ElNaggar AC; Bid HK; Wallbillich JJ; Bixel K; Bolyard C; Suarez AA; Kaur B; Kuppusamy P; Hays J; Goodfellow PJ; Cohn DE; Selvendiran K
Oncogene; 2017 Jan; 36(2):168-181. PubMed ID: 27292260
[TBL] [Abstract][Full Text] [Related]
4. The Proprotein Convertase Furin Contributes to Rhabdomyosarcoma Malignancy by Promoting Vascularization, Migration and Invasion.
Jaaks P; D'Alessandro V; Grob N; Büel S; Hajdin K; Schäfer BW; Bernasconi M
PLoS One; 2016; 11(8):e0161396. PubMed ID: 27548722
[TBL] [Abstract][Full Text] [Related]
5. NANOG regulates epithelial-mesenchymal transition and chemoresistance through activation of the STAT3 pathway in epithelial ovarian cancer.
Liu S; Sun J; Cai B; Xi X; Yang L; Zhang Z; Feng Y; Sun Y
Tumour Biol; 2016 Jul; 37(7):9671-80. PubMed ID: 26801672
[TBL] [Abstract][Full Text] [Related]
6. IGF1R predicts better survival in high-grade serous epithelial ovarian cancer patients and correlates with hCtr1 levels.
Deo A; Chaudhury S; Kannan S; Rekhi B; Maheshwari A; Gupta S; Ray P
Biomark Med; 2019 May; 13(7):511-521. PubMed ID: 31140856
[No Abstract] [Full Text] [Related]
7. CEMIP promotes ovarian cancer development and progression via the PI3K/AKT signaling pathway.
Shen F; Zong ZH; Liu Y; Chen S; Sheng XJ; Zhao Y
Biomed Pharmacother; 2019 Jun; 114():108787. PubMed ID: 30925458
[TBL] [Abstract][Full Text] [Related]
8. M2-like tumor-associated macrophages-secreted EGF promotes epithelial ovarian cancer metastasis via activating EGFR-ERK signaling and suppressing lncRNA LIMT expression.
Zeng XY; Xie H; Yuan J; Jiang XY; Yong JH; Zeng D; Dou YY; Xiao SS
Cancer Biol Ther; 2019; 20(7):956-966. PubMed ID: 31062668
[No Abstract] [Full Text] [Related]
9. PDZ and LIM domain protein 4 suppresses the growth and invasion of ovarian cancer cells via inactivation of STAT3 signaling.
Jia Y; Shi H; Cao Y; Feng W; Li M; Li X
Life Sci; 2019 Sep; 233():116715. PubMed ID: 31376371
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of the recently identified oncogene REDD1 correlates with tumor progression and is an independent unfavorable prognostic factor for ovarian carcinoma.
Chang B; Meng J; Zhu H; Du X; Sun L; Wang L; Li S; Yang G
Diagn Pathol; 2018 Nov; 13(1):87. PubMed ID: 30428884
[TBL] [Abstract][Full Text] [Related]
11. Hematogenous metastasis of ovarian cancer: rethinking mode of spread.
Pradeep S; Kim SW; Wu SY; Nishimura M; Chaluvally-Raghavan P; Miyake T; Pecot CV; Kim SJ; Choi HJ; Bischoff FZ; Mayer JA; Huang L; Nick AM; Hall CS; Rodriguez-Aguayo C; Zand B; Dalton HJ; Arumugam T; Lee HJ; Han HD; Cho MS; Rupaimoole R; Mangala LS; Sehgal V; Oh SC; Liu J; Lee JS; Coleman RL; Ram P; Lopez-Berestein G; Fidler IJ; Sood AK
Cancer Cell; 2014 Jul; 26(1):77-91. PubMed ID: 25026212
[TBL] [Abstract][Full Text] [Related]
12. TM4SF1 is a potential target for anti-invasion and metastasis in ovarian cancer.
Gao C; Yao H; Liu H; Feng Y; Yang Z
BMC Cancer; 2019 Mar; 19(1):237. PubMed ID: 30876464
[TBL] [Abstract][Full Text] [Related]
13. A ROS/STAT3/HIF-1α signaling cascade mediates EGF-induced TWIST1 expression and prostate cancer cell invasion.
Cho KH; Choi MJ; Jeong KJ; Kim JJ; Hwang MH; Shin SC; Park CG; Lee HY
Prostate; 2014 May; 74(5):528-36. PubMed ID: 24435707
[TBL] [Abstract][Full Text] [Related]
14. IL6-induced metastasis modulators p-STAT3, MMP-2 and MMP-9 are targets of 3,3'-diindolylmethane in ovarian cancer cells.
Zou M; Zhang X; Xu C
Cell Oncol (Dordr); 2016 Feb; 39(1):47-57. PubMed ID: 26510945
[TBL] [Abstract][Full Text] [Related]
15. miRNA-301b-3p accelerates migration and invasion of high-grade ovarian serous tumor via targeting CPEB3/EGFR axis.
Liu F; Zhang G; Lv S; Wen X; Liu P
J Cell Biochem; 2019 Aug; 120(8):12618-12627. PubMed ID: 30834603
[TBL] [Abstract][Full Text] [Related]
16. Multifunctional APJ Pathway Promotes Ovarian Cancer Progression and Metastasis.
Neelakantan D; Dogra S; Devapatla B; Jaiprasart P; Mukashyaka MC; Janknecht R; Dwivedi SKD; Bhattacharya R; Husain S; Ding K; Woo S
Mol Cancer Res; 2019 Jun; 17(6):1378-1390. PubMed ID: 30858172
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylation of STAT3 at Tyr705 regulates MMP-9 production in epithelial ovarian cancer.
Jia ZH; Jia Y; Guo FJ; Chen J; Zhang XW; Cui MH
PLoS One; 2017; 12(8):e0183622. PubMed ID: 28859117
[TBL] [Abstract][Full Text] [Related]
18. Dual targeting of IGF-1R and ErbB3 as a potential therapeutic regimen for ovarian cancer.
Camblin AJ; Tan G; Curley MD; Yannatos I; Iadevaia S; Rimkunas V; Mino-Kenudson M; Bloom T; Schoeberl B; Drummond DC; Lugovskoy AA; Louis CU; Askoxylakis V
Sci Rep; 2019 Nov; 9(1):16832. PubMed ID: 31728045
[TBL] [Abstract][Full Text] [Related]
19. HOXB4 promotes the malignant progression of ovarian cancer via DHDDS.
Li N; Gou JH; Xiong J; You JJ; Li ZY
BMC Cancer; 2020 Mar; 20(1):222. PubMed ID: 32178630
[TBL] [Abstract][Full Text] [Related]
20. The proprotein convertase furin in tumour progression.
Jaaks P; Bernasconi M
Int J Cancer; 2017 Aug; 141(4):654-663. PubMed ID: 28369813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
